GSK3B and Alzheimer disease: Transcriptomic data revealed that hTau N368 disrupted multiple AD‐associated signaling pathways in the hTau N368‐loaded mossy cells, including the remarkably reduced levels of synapse‐associated proteins, inhibition of AKT and activation of glycogen synthase kinase‐3β (GSK‐3β).